Literature DB >> 25443364

Oplopanax elatus (Nakai) Nakai: chemistry, traditional use and pharmacology.

Alexander N Shikov1, Olga N Pozharitskaya2, Valery G Makarov2, Wen-Zhi Yang3, De-An Guo3.   

Abstract

Oplopanax elatus (Nakai) Nakai, a member of the ancient angiosperm plant family Araliaceae, is used for the treatment of different disorders in the medicine systems of China, Russia, and Korea, and was designated in Russia as a classical adaptogen. Despite extensive studies of classical adaptogens, there are comparatively few reports concerning the chemical composition and pharmacological effects of O. elatus in English. The plant is a potential source of saponins, flavonoids, anthraquinones, terpenes, and other active compounds. Experimental studies and clinical applications have indicated that O. elatus possesses a number of pharmacological activities, including adaptogenic, anti-convulsant, anti-diabetic, anti-fungal, anti-inflammatory, anti-oxidant, blood pressure modulating, and reproductive function effects. In this review, the chemistry, safety, and therapeutic potential of O. elatus are summarized and highlighted to encourage the further development of this plant.
Copyright © 2014 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptogen; Asthenia; Chemistry; Diabetes; Oplopanax elatus; Physical and mental fatigue; Safety

Mesh:

Substances:

Year:  2014        PMID: 25443364     DOI: 10.1016/S1875-5364(14)60111-4

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  11 in total

Review 1.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

2.  Falcarindiol and dichloromethane fraction are bioactive components in Oplopanax elatus: Colorectal cancer chemoprevention via induction of apoptosis and G2/M cell cycle arrest mediated by cyclin A upregulation.

Authors:  Chong-Zhi Wang; Yun Luo; Wei-Hua Huang; Jinxiang Zeng; Chun-Feng Zhang; Mallory Lager; Wei Du; Ming Xu; Chun-Su Yuan
Journal:  J Appl Biomed       Date:  2021       Impact factor: 1.797

3.  Shifts in rhizosphere microbial communities in Oplopanax elatus Nakai are related to soil chemical properties under different growth conditions.

Authors:  Wanying Li; Xiujuan Lei; Rui Zhang; Qingjun Cao; He Yang; Nanqi Zhang; Shuangli Liu; Yingping Wang
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

Review 4.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

5.  Adventitious root cultures of Oplopanax elatus inhibit LPS-induced inflammation via suppressing MAPK and NF-κB signaling pathways.

Authors:  Wen Tian; Xuan-Mei Piao; Cheng-Ri Yin; Xiao-Long Jiang; Hao-Ding Sun; Xiao-Li An; Jun Jiang; Mei-Lan Lian
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-09-16       Impact factor: 2.416

Review 6.  A Critical Review to Identify the Domains Used to Measure the Effect and Outcome of Adaptogenic Herbal Medicines.

Authors:  Sophia E Gerontakos; David Casteleijn; Alexander N Shikov; Jon Wardle
Journal:  Yale J Biol Med       Date:  2020-06-29

7.  Polyyne-Enriched Extract from Oplopanax elatus Significantly Ameliorates the Progression of Colon Carcinogenesis in ApcMin/+ Mice.

Authors:  Xin Qiao; Wei Sun; Chongzhi Wang; Li Zhang; Ping Li; Xiaodong Wen; Jie Yang; Chunsu Yuan
Journal:  Molecules       Date:  2017-09-22       Impact factor: 4.411

8.  Chemical profiling of root bark extract from Oplopanax elatus and its in vitro biotransformation by human intestinal microbiota.

Authors:  Jin-Yi Wan; Jing-Xuan Wan; Shilei Wang; Xiaolu Wang; Wenqian Guo; Han Ma; Yuqi Wu; Chong-Zhi Wang; Lian-Wen Qi; Ping Li; Haiqiang Yao; Chun-Su Yuan
Journal:  PeerJ       Date:  2021-11-24       Impact factor: 2.984

Review 9.  Production of bioactive plant secondary metabolites through in vitro technologies-status and outlook.

Authors:  Christoph Wawrosch; Sergey B Zotchev
Journal:  Appl Microbiol Biotechnol       Date:  2021-09-01       Impact factor: 4.813

Review 10.  Oplopanax horridus: Phytochemistry and Pharmacological Diversity and Structure-Activity Relationship on Anticancer Effects.

Authors:  Kai Wu; Chong-Zhi Wang; Chun-Su Yuan; Wei-Hua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.